Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.

Published in: The Annals of pharmacotherapy (2021)

Rilonacept is a safe, once weekly, subcutaneously administered IL-1 "trap," indicated for the treatment of RP, and reduction in risk of recurrent pericarditis in adults and children ≥12 years of age.

Keyphrases